Accelerating Breakthrough Therapies with
AI-Powered Clinical Intelligence
We partner with biopharma innovators, combining deep therapeutic expertise with advanced AI to deliver high-quality data, reduce risk, and bring life-changing treatments to patients, faster.
Partner With UsAn Integrated Suite of Services
We provide an end-to-end partnership, designed to support your clinical development journey from initial strategy to regulatory approval and beyond.
Full-Service Clinical Development
We provide end-to-end support for your clinical trials. Our expertise spans the entire lifecycle, from early-phase development, FIH, and dose escalation studies to pivotal Phase 3 trials and post-marketing commitments. We specialize in complex study designs for oncology, hematology, and rare diseases, ensuring diligent patient safety monitoring, robust data collection, and operational excellence across global sites.
Explore Clinical Development →
Strategic Regulatory Support
Navigate the complex regulatory landscape with a proven partner. We specialize in strategies for expedited approval pathways, including Fast Track, Breakthrough Therapy, and Accelerated Approval. Our team has direct experience with over 27 INDs, 9 NDAs, and 3 BLAs, providing invaluable insights to de-risk your submission and optimize your path to market for high unmet medical need therapies.
Learn About Our Regulatory Edge →Safety & Pharmacovigilance
Comprehensive safety monitoring and PV operations to protect patients and support regulatory reporting. We provide signal detection, aggregate reporting, and inspection readiness to ensure your program meets global safety standards. Our physician-led safety oversight ensures expert benefit-risk assessment and regulatory preparedness.
Explore Safety →
AI-Powered Data & Analytics
Our AI platform transforms clinical trial data into a strategic asset. We offer real-time data integrity checks, predictive analytics for site performance and patient enrollment, and advanced safety signal detection. By handling huge volumes of multi-modal data, we accelerate analysis and provide the high-quality evidence needed for faster, more confident regulatory submissions.
Discover AI Capabilities →Deep Therapeutic Expertise
Our profound understanding of complex diseases is the foundation of our success. We bring specialized clinical and operational experience to the most challenging areas of drug development.
Oncology & Hematology
Expertise in CAR-T, ADCs, and oncolytic virus therapies. Deep experience in relapsed/refractory metastatic cancers.
130+ Oncology Trials LedRare Diseases
Agile and patient-centric solutions for studies with unique challenges and high unmet needs.
Orphan Drug Designation SupportCell & Gene Therapy
Navigating the complexities of advanced therapies from clinical strategy to regulatory filing and commercialization.
Direct CAR-T BLA Approval ExperienceValue Delivered, Quantified
Our AI-powered, expert-led model delivers tangible results, improving the speed, quality, and efficiency of your clinical trials.
Our Leadership
Founded by industry veterans who have successfully bridged the gap between cutting-edge clinical science and transformative technology.
Dr. Ashok Srivastava
MD, PhD, MBAPresident & Chief Medical Officer
A board-certified oncologist with over 17 years of global leadership in oncology R&D, instrumental in filing dozens of INDs/NDAs/BLAs and a leading expert in CAR-T cell therapies.
Elias Tharakan
Chief Executive & Technology Officer
A visionary lifesciences technology executive who architected a leading unified eClinical SaaS platform that powered over 1,000 trials and contributed to dozens of drug approvals.
Ready to Redefine Clinical Development?
Let's discuss how AyurDatta can become the catalyst for your next breakthrough. Contact us to schedule a consultation with our experts.
Get in Touch